Arkolith/Insider Trading/NAVB/Form 4

Scott John K Jr.

Director, 10% OwnerNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed May 3, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2022Grant(A)3K—$08.1M
Apr 10, 2022Buy(P)3K——3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2022Buy(P)2K$0.80$1K2K
Apr 10, 2022Sell(S)50K$2.30$115K0

Transaction Codes

A
Grant / award
P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-010726) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML